Joint British Diabetes Society for Inpatient care

The Joint British Diabetes Society for Inpatient Care (JBDS-IP) aims to improve inpatient diabetes care across the UK through the development and use of high-quality, evidence-based guidelines and inpatient care pathways.

Guidelines

• Diabetes at the Front Door (March 2020)

• Inpatient Care of the Frail Older Adult with Diabetes (October 2019)

• A good inpatient diabetes service (July 2019)

• Management of glycaemic control in pregnant women with diabetes on obstetric wards and delivery units (August 2017) 

• Management of diabetes in adults and children with psychiatric disorders in inpatient settings (August 2017)

• Management of adults with diabetes on the haemodialysis unit (April 2016)

• Management of adults with diabetes undergoing surgery and elective procedures: improving standards (revised March 2016)

• Discharge planning for adult inpatients with diabetes (October 2015)

• Management of hyperglycaemia and steroid (glucocorticoid) therapy (October 2014)

• Use of variable rate intravenous insulin infusion (VRIII) in medical inpatients (October 2014)

• Admissions avoidance and diabetes: guidance for Clinical Commissioning Groups and clinical teams (December 2013)

• Management of diabetic ketoacidosis in adults (September 2013)

• Hospital management of hypoglycaemia in adults with diabetes mellitus (January 2020)

• Management of the hyperosmolar hyperglycaemic state (HHS) in adults with diabetes (August 2012)

• Glycaemic management during the inpatient enteral feeding of stroke patients with diabetes (August 2012)

• Self-management of diabetes in hospital (March 2012)

The Rowan Hillson Insulin Safety Award

The Rowan Hillson awards aim to promote excellence in insulin safety. Each year the awards focus on a specific topic.

• 2016 joint winner: Best joint pharmacy and diabetes team initiative to improve insulin and prescribing safety in hospital, A pharmacist led intiative to support insulin self administration, Sheffield Teaching Hospital NHS Foundation Trust (PDF, 261KB)

• 2016 joint winner: Best joint pharmacy and diabetes team initiative to improve insulin and prescribing safety in hospital, Derby Diabetes Inpatient Improvement Projects ( DIPs), Royal Derby Teaching Hospital NHS Foundation Trust (PDF, 407KB)

• 2016 runner up: Operation Pharmacist: Ending the Highs and Lows of Diabetes, St George’s University Hospitals NHS Foundation Trust (PDF, 637KB)

• 2015 winner: innovative use of ward glucose systems to reduce inpatient hypoglycaemia, Ipswich Hospital NHS Trust (Word, 26KB)

• 2014 winner: insulin prescription chart, Nottingham University Hospitals NHS Trust (PDF, 1MB)

• 2014 runner up: insulin prescription chart, East Sussex Healthcare NHS Trust (PDF, 730KB)

  East Sussex Healthcare NHS Trust also produced the following specific charts:East Sussex Healthcare NHS Trust also produced the following specific charts:
  • IV insulin DKA and HHS chart (PDF, 127KB)
  • IV insulin ACS chart (PDF, 126KB)
  • IV insulin surgey NBM chart (PDF, 126KB)

About JBDS-IP

The Joint British Diabetes Societies for Inpatient Care (JBDS-IP) was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and propose standards of care within secondary care organisations’. JBDS-IP is supported by Diabetes UK, the Association of British Clinical Diabetologists (ABCD) and the Diabetes Inpatient Specialist Nurse (DISN) UK Group. JDBS-IP also work with NHS England, TREND-UK and other professional organisations. 

JBDS-IP consists of a number members and all four nations are represented. Members meet face-to-face twice a year and also connect via regular teleconferences. 

Chair 

Professor Ketan Dhatariya, Norfolk and Norwich University Hospitals NHS Foundation Trust

JBDS-IP Group

• Dr Ahmed Al-Sharefi, Newcastle Hospitals NHS Foundation Trust
• Dr Belinda Allan, Hull and East Yorkshire Hospital NHS Trust
• Mr Erwin Castro, East Sussex Healthcare NHS Trust
• Dr Jason Cheung, Norfolk and Norwich University Hospitals NHS Foundation Trust
• Dr Umesh Dashora, East Sussex Healthcare NHS Trust
• Dr Parijat De, Sandwell and West Birmingham NHS Trust
• Dr Ketan Dhatariya, (Norwich), Chair, Joint British Diabetes Societies (JBDS) for Inpatient Care 
• Dr Daniel Flanagan, Plymouth Hospitals NHS Trust
• Dr Stella George, East and North Hertfordshire NHS Trust
• Dr Chris Harrold, University Hospitals Coventry and Warwickshire NHS Trust
• Dr Masud Haq, Maidstone and Tunbridge Wells NHS Trust
• Dr Kath Higgins, University Hospitals of Leicester NHS Trust
• Mrs June James, University Hospitals of Leicester NHS Trust
• Mr David Jones, Diabetes UK
• Dr Meera Ladwa, King's College Hospital NHS Foundation Trust
• Dr Anthony Lewis, Belfast Health and Social Care Trust, Northern Ireland
• Ms Flora Mates, Diabetes UK
• Dr Omar Mustafa, King’s College Hospital NHS Foundation Trust, London
• Dr Dinesh Nagi, Mid Yorkshire Hospitals NHS Trust
• Mr Philip Newland-Jones, University Hospital Southampton NHS Foundation Trust
• Professor Gerry Rayman, The Ipswich Hospital NHS Trust
• Dr Stuart Ritchie, NHS Lothian
• Dr Aled Roberts, Cardiff and Vale University Health Board
• Professor Mike Sampson, Norfolk and Norwich University Hospitals NHS Foundation Trust 
• Professor Alan Sinclair, Director Diabetes Frail Ltd 
• Mrs Debbie Stanisstreet, East and North Hertfordshire NHS Trust
• Mrs Ether Walden, Norfolk and Norwich University Hospitals NHS Foundation Trust
• Ms Olivia Burr, Diabetes UK 
• Dr Peter Winocour, East and North Hertfordshire NHS Trust

For more information on JBDS-IP contact Christine Jones, Norfolk and Norwich University Hospitals NHS Foundation Trust, at christine.jones@nnuh.nhs.uk.

2012 JDBS-IP survey

A SurveyMonkey of JBDS-IP guidelines undertaken at the end of 2012 revealed:

• Guidelines have been actively distributed (>21,000 copies, excluding downloads)
• 85-100 per cent of responding teams were aware of the guidelines
• >90 per cent adoption in 118 UK Trusts for older guidelines, and around 50 per cent for 2012 guidelines
• Guidelines were rated highly in terms of patient safety, overall quality and clinical value.